chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported he got the second COVID vaccine at 8:33 am at the  Center at an event run by Health Clinic. At 10 am he began to feel unwell describing "disorientation" which upon further explanation seems he is describing difficulty with his proprioception, ie not able to tell where his body is in space, and disequilibrium, ie having to stop and hold on to something while walking. This lasted most of the day and subsided by evening. He has continued to have ongoing shorter episodes 3-4 times per day lasting 5-10 minutes. In addition he has noted increasing weakness in his right thigh, particularly when going from sitting to standing and the through swing while walking. He describes these as "paralytic attacks" that occur once or twice per day and last hours. Both symptoms are similar to those he had post CVA in 2019 and greatly improved with PT and home exercises. In addition he has noted fecal urgency and fecal incontinence in the last couple of weeks, he is unsure if this is directly related to the vaccine.
Delayed skin reaction 2 inches from injection site. Approximately 2x4 inches oval. Sore, red, and itchy.   I took Benadryl and placed an ice pack on it per online recommendation.
Patient reports that her arm, elbow, neck, and shoulders have been hurting her enough to immobilze her arm since approx. 12 hours after injection.  Within 24 hours of injection patient felt nausea, chills, achy upper torsoe, and she had diarrhea x 2.  Patient reports 48 hours after injection that the nausea and chills are gone but she is still feeling pain that has her immobilizing her arm and she cannot turn her neck from side to side.  Patient was advised to use tylenol or Motrin and seek emergency medical attention if any of these s/s worsened.  Patient also advised to follow up with her primary care providered if s/s are not better in 5 days.
On 5/25 patient began experiencing chest pain while walking. Chest pain also was positional. It began to worsen and did not resolve with rest so the patient presented to the ED on 5/25. He was found to have a high sensitivity troponin I initially elevated to 85. He was admitted to the local ICU ask his chest pain was worsening and his troponin was rising. In the ICU he was monitored with telemetry and troponin continued to rise to a maximum of 2144, and downtrended to 686 on 5/27 after monitoring. When he initially presented there was immediate concern this was COVID vaccine-associated myocarditis. EKGs were followed and on 5/26 he had some ST changes, but these improved and he had a normal EKG on 5/27. He had an ECHO on 5/26 that was normal and showed EF of 64%. Cardiology was consulted and recommended starting a 10 day course of ibuprofen. He was deemed safe for discharge on 5/27 with cardiology follow up per guidelines. Symptoms had improve.  He has an activity restriction for the next month.
Large painful  red patch on left arm. The area increased in size until it covered the skin from my injection site down to my entire bicep area. Color was red and purplish and painful to the touch but not a rash. It looked like a birth mark or large bruise. By day 5 is began to fade. By day 7 it was still visible but almost gone. Treatment was benadryl and ibuprofen. Self treated.
Patient received shingles vaccine on 11/3/12, then broke out in rash on arms and legs the next day. No other symptoms experienced, patient improving.
Extreme pain in my left arm and shoulder from the Pneumovax 23 shot it's three days later and I have a little range of motion and continued pain in my left shoulder and upper arm. Some fatigue and lil difficulty deep inhaling. The vaccine was given at pharmacy in my zip code.
late second dose of Shingrix,18Aug2020 and the second one on 25Oct2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number PM35L, expiry date 4th February 2023) for prophylaxis.   Previously administered products included shingrix (1st dose received on 18th August 2020).   On 25th October 2021, the patient received the 2nd dose of Shingrix. On 25th October 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: Pharmacist reported that the patient was vaccinated with 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. The reporter consented to follow up.
received 1st dose but not 2nd; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that the patient received the 1st dose of Shingrix but did not return within 2-6 months for the 2nd dose, which led to incomplete course of vaccination. The reporter wanted to know if the patient had to retake the 1st dose of Shingrix. The reporter did not have the patient identifiers or the exact date of the first dose at the time of reporting. The reporter consented to follow up via post.
Within 4 hours of administration developed local reaction of erythema with progession of site to cover upper 1/3 third of upper arm with swelling to elbow.  Developed swelling at back of throat with upper respiratory congestion lasting approxmiately 2 days.  Given Benedryl for symptoms
2 days after vaccination DTaP in left deltoid, see for red swollen tender rash from shoulder to elbow.
Facial red blotchy rash starting evening of 6/5/07. Rash on arms, trunk on 6/6/07 - denies itching. Rash faded slightly on face - persists in arms, trunk, slight rash on legs was given Motrin 2 x 6/5, 1 x 6/6. 6/7/07 Temperature 99.1 with temporal scan.
This spontaneous report as received from a pharmacist via field representative refers to a 62 year old female patient. The patient's pertinent medical history included Sjogren's syndrome. On an unknown date, the patient was mistakenly vaccinated with ZOSTAVAX 0.65 ml, subcutaneously instead of PNEUMOVAX 23. The patient asked for PNEUMOVAX 23 but was given ZOSTAVAX by mistake. No adverse effects were reported. Additional information has been requested.
Throwing up; Sore throat; Stuffy nose; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 06May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 12May2021, outcome "unknown", described as "Sore throat"; NASAL CONGESTION (non-serious) with onset 12May2021, outcome "unknown", described as "Stuffy nose"; HEADACHE (non-serious) with onset 12May2021, outcome "unknown", described as "Headache"; VOMITING (non-serious) with onset 13May2021, outcome "unknown", described as "Throwing up".  Additional information: The patient stated that she got the second dose of the Pfizer Covid-19 vaccine on 06May2021. Yesterday she had a sore throat, stuffy nose and headache. Today it was worst, she was throwing up. Is it possible to have a reaction 1 week after receiving the Pfizer COVD-19 vaccine?  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
24 hours later, chills; Vomiting; Diarrhea; Headache; Dose number: 3; Sore left arm; Fatigue; This is a spontaneous report from a contactable reporter (nurse). The reporter is the patient.  A 55-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 01Dec2021 at 14:00 (Lot number: FJ1620) at the age of 55 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medications included: LEVOTHYROXINE; VITAMIN D; LIPITOR; ZINC and TYLENOL. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EH9899, Route of administration: Unspecified),administered on an unknown date, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE ,Lot Number: EK9231, Route of administration: Unspecified), administered on an unknown date, for COVID-19 immunisation The following information was reported: IMMUNISATION (non-serious) with onset 01Dec2021 at 14:00, outcome "unknown", described as "Dose number: 3"; PAIN IN EXTREMITY (non-serious) and FATIGUE (non-serious), both with onset 01Dec2021, outcome "recovering", described as "Sore left arm and fatigue same day"; CHILLS (non-serious), VOMITING (non-serious),DIARRHOEA (non-serious) and HEADACHE (non-serious), all with onset 02Dec2021, outcome "recovering", described as "24 hours later, chills, vomiting, diarrhea, headache". The patient underwent the following laboratory tests and procedures: SARS-CoV2 test: (03Dec2021) pending. Therapeutic measures were not taken as a result of pain in extremity, fatigue, chills, vomiting, diarrhoea and headache.  Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had been tested for COVID-19 and the results were pending. The events resulted in doctor or other healthcare professional office/clinic visit.
Fever, chills, weakness, body ache, dizziness didn't get out of bed for over 24 hours. Took Tylenol for relief. still feeling weak. can't stand up long without feeling dizzy.
Dizziness. Felt faint, likely dehydrated - resolved with water. Vitals wnl.
Patient picked up cephalexin yesterday from the pharmacy. He stated that his hand had been swollen since he received the vaccine. I spoke to him and his wife a few times after the vaccine was given, and that was the first time his hand being swollen was ever mentioned.
Dose was given at 2:20pm. On March 6th By 10pm tiredness began Slept for 11 hours Woke up on the 7th with chills which lasted on and off as doses of tylenol wore off Muscle aches in arms and legs all day. Slept throughout the day feeling as if I could not get fully awake.  By 10pm on the 7th,the night after the shot, I was back in bed. Woke up on the 8th feeling rested, no more body aches or chills....but a lump had appeared over night in my left armpit...i assume a swollen lymph node as it is on the side of the injection.  Today is the 9th and the lymph node is still swollen.
On 11/20/2003, mom calls us at 14:00 reporting her son had a sore arm, she said she sent him to school did not look at it.  New after school low grade fever, throwing up, arm swollen.  At 15:00 reports shortness of breath, told to go to ER, for shortness of breath.
I had the vaccine Sunday night and experienced fatigue that night, and then developed arm soreness that lasted for a little over 24 hours. I also developed minor body aches and felt crummy Monday and Tuesday. I was then fine for the rest of that week. Monday, January 4th at 7:30 PM, I felt something tingly, burning, and hot on my left arm. When I looked at it, I had a large round red rash that had a knot and was hot to the touch and itchy. At 3:30 AM on Tuesday morning, I woke up in pain and crying. I went to Urgent Care to have it assessed. The doctor diagnosed it as cellulitis in relation to an infection at the injection site and gave me an antibiotic and drew around it with a surgical marker. He told me to go to my PCP if it grew outside of the line or to the ER if I developed severe symptoms. On Wednesday, it had grown and was not getting any better and had started forming blisters. I called my PCP and he told me to take 2 Loratadine every 24 hours and to come in if it was not better by Friday. It appeared to be getting better and I was fine on Thursday. Friday morning, I woke up in pain again. The rash had spread across the majority of my upper arm. It was red and painful and itching with heat. I went in to see my PCP and he diagnosed it as an allergic reaction to the vaccine. He gave me a steroid, which seems to be suppressing the rash and symptoms. I still have a rash and itchiness, but my physician said it could last for another week or two until it goes away.
Swelling and red rash on arm at site of injection which is still present, body ache and headache, general malaise the day following the injection resolving within 24 hours
Has some seriously bruises; knees locked up, lost his balance, lost control of his legs; knees locked up; lost his balance; A spontaneous report was received from consumer concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, knees locked up, lost his balance, lost control of legs and some serious bruises.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 12-Feb-2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 18-Feb-2021, six days later, patient reported that his knees locked up, he lost his balance and lost control of his legs.  He stated that as of 22-Feb-2021, he has some serious bruises.  Laboratory details were not provided.  No treatment information was provided.   The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events was not applicable.   The outcome of the events,  knees locked up, lost his balance, lost control of legs and some serious bruises, was unknown.; Reporter's Comments: This case concerns a male patient, who experienced a serious unexpected event of Loss of control of legs among others,7 days after receiving 2nd dose of mRNA- 1273 (Lot# Unknown). Very limited information regarding this event has been provided at this time. Further information has been requested.
multiple unspecified patients received improperly stored doses of vaccines; This spontaneous report has been received from a physician referring to an unspecified number of patients of unknown age and gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.   On an unknown date, the patients were vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent(ROTATEQ), oral (indication, strength, frequency, dose, lot # and expiration date were not provided) for prophylaxis. Other suspect therapies included measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (indication, strength, frequency, dose, route, lot # and expiration date were not provided) for prophylaxis., measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (indication, strength, frequency, dose, route, lot # and expiration date were not provided) for prophylaxis; and varicella virus vaccine live (oka/merck)(VARIVAX) (indication, strength, frequency, dose, route, lot # and expiration date were not provided) for prophylaxis.  The rotavirus vaccine, live, oral, pentavalent(ROTATEQ) vaccine was exposed to a temperature range of 47°F, during a time frame of 24 hours. measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) was exposed to a temperature of 47°F during a time frame of 33 hours; measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was stored at above 47°F during 33 hours; and measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was stored at a temperature above 46°F during 33 hours.
I collapsed and fainted. I was convulsing and had a seizure. It happened 5 minutes after the vaccine was administered to me. I woke up shaking and sweating. Eyes rolling. Unstable. Disoriented and terrified. I threw up water that was given to me. Within 20 minutes I was able to stand up and walk. I was extremely nauseous remainder of the day.
Chills; Low grade fever; Shoulder pain; left arm pain; back pain; swollen lymph node in left axillary area; fatigue; headache; This is a spontaneous report from a contactable pharmacist, the patient. A 42-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 15Mar2021 at 11:15 hours (at the age of 42-years) as a single dose for COVID-19 immunisation. The patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 22Feb2021 at 11:15 hours as a single dose for COVID-19 immunisation. The patients medical history included hypertension. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included hydrochlorothiazide (MANUFACTURER UNKNOWN) 12.5 (unit unspecified) once daily (QD). The patient received this medication within 2 weeks of vaccination and exact therapy dates and indication for it was not reported. On 16Mar2021, the patient experienced chills, low grade fever, shoulder pain, left arm pain, back pain, swollen lymph node in left axillary area, fatigue and headache. The patient received Motrin as a treatment medication. On an unknown date in Mar2021, the patient was recovered from the events chills, low grade fever, shoulder pain, left arm pain, back pain, swollen lymph node in left axillary area, fatigue and headache.   No follow up attempts are needed. No further information is expected.
Patient is an 85 y/o male with PMH significant for HFrEF, CAD s/p CABG, Afib s/p ICD, AAA, T2DM, HTN, HLD, asthma, OSA, and hypogonadism. Patient had HBPC visit on 1/7/19 where his second Shingrix dose was administered. Admitted the next day after receiving the vaccine with complaints of sudden onset of SOB, nausea, and a sense of impending doom. Patient also reported having urinary incontinence, new onset L abdominal pain, and difficulty sleeping. Workup was unrevealing so it was determined to be an adverse reaction to Shingrix. Discharged after one day in stable condition without precautions since he had completed his Shingrix schedule. NauseaVomiting & shortness of breath, sense of impending doom, abdominal pain, urinary incontinence, difficulty sleeping, observation.
Severe premature ventricular beats began to occur on the second day after the first injection. At present, I have been taking metoprololhe to control premature beats.
Patient describes as flu-like symptoms, aches and pains, fever, chills, nausea, weakness, and "knot" at injection site
itchy red rash at the site of injection,  area is swollen and warm to the touch,  upper arm is also sore rash cover most of upper arm area  it appeared a week after vaccination and has lasted 2 days so far with some improvement on day 2 of event
vesicular rash; small vesicles that became dry; small vesicles that became dry; This case was reported by a physician via call center representative and described the occurrence of vesicular rash in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number TB2PK, expiry date 5th October 2021) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, 2 days after receiving Shingrix, the patient experienced vesicular rash, vesicles and dry skin. On an unknown date, the outcome of the vesicular rash was not recovered/not resolved and the outcome of the vesicles and dry skin were unknown.   It was unknown if the reporter considered the vesicular rash, vesicles and dry skin to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix vaccine on right deltoid and 2 days after receiving the vaccine, patient developed a vesicular rash on the inner part of her right arm. The reporter stated that there were multiple small vesicles that became dry and one of the vesicles has popped. Emergency visit was Required. The reporter was in a rush and needed to get off of the phone to see patients. Therefore, reporter did not provide vaccination date or dose number.
Onset of left lower leg cramping and pain on 12/8/21.  Progressive worsening with ambulation.  Onset of expiratory wheezes at rest, intermittently with non-productive cough. 1/22/22: shortness of breath on exertion (while in cold temperatures only) with chest heaviness.  Resolved quickly with rest. 1/29/22: worsening SOB and difficulty breathing with exertion, chest pressure and discomfort.  2/2/22: office appointment with primary care provider.  EKG with abnormal ST segment abnormality.  Transported to ED via EMS.  Labs significant for elevated troponin.  Imaging revealed saddled pulmonary emboli and left femoral DVT. Transferred to hospital for Heparin drip.  Discharged on 2/4/22 for outpatient follow up and management on oral anticoags.
Pt states that she became nauseated at 9 PM and vomited egg smelling substance several times. She has been drinking fluids to stay hydrated. She reports NO rash, NO difficulty breathing at present, and symptoms seem to be improving. Pt was advised to seek medical attention if does not resolve or if she starts to feel worse.
started with arm ache going down arm from injection site to elbow and into arm pit within 5 minutes of receiving the vaccine mild nasal congestion started about 6 hours after the injection along with mild intermittent headaches that were mostly on the left side of my head the first 24 hours were mild nasal congestion, mild headaches the second 24-48 hours were continued mild congestion, nasal sinus discomfort/achiness/burning, and mild headaches, discomfort at injection site 48 hours -72 hours were continued mild headaches the migrated to different parts of my head (top, side frontal area, back, etc), and some intermittent sinus discomfort 72 hours - mild intermittent headaches still persist
Headache Headache lasted 24 hours. she has a h/o migraine but states that this headache was worse Narrative:
This spontaneous report was received from a clinical medical assistant who refers to a patient of unknown age and gender. On 09-SEP-2013 the patient received less than the recommended first dose of GARDASIL (route not reported, lot number reported as J006879, exp. 04-DEC-2015) due to leaking GARDASIL prefilled syringe. No adverse effect reported. POC has been already involved. Additional information has been requested.
pt had swelling and redness in the arm that the injection was given .  Pt also had muscle chest pain in her shoulder and chest also on the side that she was given the injection.
Breakthrough case admission after 4 vaccines Pfizer 4/14/21 LOt# EW0158;  Pfizer 5/5/21 Lot# EW0179;  Pfizer 12/4/21 Lot# FJ8757;  Pfizer 5/2/22 Lot# FM9992
pt became pale, limp, listless & had jerking movements for 30 mins 4 hrs p/vax; MD called did not return call for 2 hrs @ that time pt seemed OK; no fever;
Returns to facility to have TB skin test read and shows red, warm area that measures 50mm with additional surrounding area of 50mm wide ring that is pink but not red, itchy.